Neoplasia — MCQs
On this page
Which of the following is NOT seen in carcinoid syndrome?
A 35-year-old lady presents with a lump in the upper outer quadrant of the breast. Histopathology shows cells in pools of mucin and faint nuclei. What is the most likely diagnosis?
Which of the following is NOT a hormonal tumor marker?
Which of the following statements about embryonal rhabdomyosarcoma is false?
Which of the following is not associated with thymoma?
Post-renal transplant lymphoma is mostly associated with which virus?
The type of mammary ductal carcinoma in situ (DCIS) most likely to result in a palpable abnormality in the breast is
In which of the following carcinomas of the breast does loss of E-cadherin play a vital role in pathogenesis?
Hereditary retinoblastomas develop the following chromosomal detection?
Metastasis to the liver is uncommon with which of the following malignancies?
Neoplasia Indian Medical PG Practice Questions and MCQs
Question 81: Which of the following is NOT seen in carcinoid syndrome?
- A. Diarrhoea
- B. Constipation (Correct Answer)
- C. Liver metastasis
- D. 5-HT secretion
Explanation: **Explanation:** Carcinoid syndrome is a paraneoplastic syndrome caused by the systemic release of vasoactive substances, primarily **Serotonin (5-HT)**, from neuroendocrine tumors. **Why Constipation is the Correct Answer:** Serotonin acts on the 5-HT3 and 5-HT4 receptors in the gastrointestinal tract to **increase intestinal motility** and secretion. Therefore, the hallmark gastrointestinal symptom of carcinoid syndrome is **secretory diarrhea**, not constipation. Constipation is clinically inconsistent with the physiological effects of excess serotonin. **Analysis of Other Options:** * **A. Diarrhoea:** This is a classic feature. Excess serotonin stimulates intestinal motility and inhibits water absorption, leading to explosive, non-bloody diarrhea. * **C. Liver Metastasis:** Primary GI carcinoid tumors (e.g., midgut) release serotonin into the portal circulation, where it is inactivated by the liver (first-pass metabolism). Carcinoid syndrome typically occurs only **after the tumor metastasizes to the liver**, allowing hormones to bypass metabolism and enter the systemic circulation directly. (Exception: Ovarian/Bronchial carcinoids). * **D. 5-HT Secretion:** Serotonin (5-hydroxytryptamine) is the primary mediator responsible for the clinical manifestations of the syndrome [1]. **NEET-PG High-Yield Pearls:** * **Diagnosis:** Best initial screening test is **24-hour urinary 5-HIAA** (a metabolite of serotonin). * **Clinical Triad:** Flushing (most common), Diarrhea, and Right-sided heart failure (Tricuspid regurgitation/Pulmonary stenosis). * **Heart Involvement:** Left-sided heart lesions are rare because serotonin is inactivated by the lungs (MAO enzyme). * **Pellagra Connection:** Chronic carcinoid can lead to **Niacin (Vitamin B3) deficiency** because tryptophan is diverted to synthesize serotonin instead of nicotinic acid. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 430-431.
Question 82: A 35-year-old lady presents with a lump in the upper outer quadrant of the breast. Histopathology shows cells in pools of mucin and faint nuclei. What is the most likely diagnosis?
- A. Adenocarcinoma
- B. Colloid carcinoma (Correct Answer)
- C. Medullary carcinoma
- D. Lobular carcinoma
Explanation: ### Explanation **Correct Answer: B. Colloid carcinoma** **Reasoning:** Colloid carcinoma (also known as **Mucinous carcinoma**) of the breast is a distinct histological subtype characterized by the presence of abundant extracellular **pools of mucin**. On histopathology, small clusters or nests of tumor cells appear to "float" within these large mucinous lakes. The description of "faint nuclei" or small, bland nuclei is consistent with the low-grade nature of these cells. This tumor typically presents in older women and has a significantly better prognosis than the common invasive ductal carcinoma (NOS) [2]. **Analysis of Incorrect Options:** * **A. Adenocarcinoma:** This is a broad category. While colloid carcinoma is a type of adenocarcinoma, the question asks for the "most likely" specific diagnosis based on the pathognomonic finding of mucin pools. * **C. Medullary carcinoma:** This subtype is characterized by large pleomorphic cells arranged in syncytial patterns with a prominent **lymphoplasmacytic infiltrate** and scant stroma [1]. It does not show extracellular mucin. * **D. Lobular carcinoma:** This is characterized by small, discohesive cells (due to loss of **E-cadherin**) typically arranged in a **"single-file" (Indian file)** pattern [1]. While it can have intracellular mucin (signet ring cells), it does not form large extracellular mucin pools. **High-Yield Pearls for NEET-PG:** * **Prognosis:** Colloid carcinoma has an excellent prognosis (10-year survival >90%). * **Gross Appearance:** The tumor often feels soft, gelatinous, or "bulky" on palpation. * **Differential Diagnosis:** Must be distinguished from *Mucocele-like lesions*, which are benign but also show mucin pools. * **Pure vs. Mixed:** To be classified as "Pure" Colloid Carcinoma, at least 90% of the tumor must show the mucinous component. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 454-456. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Breast, pp. 1068-1069.
Question 83: Which of the following is NOT a hormonal tumor marker?
- A. b-HCG
- B. Calcitonin
- C. Catecholamine
- D. Neuron-specific enolase (Correct Answer)
Explanation: **Explanation:** The correct answer is **Neuron-specific enolase (NSE)** because it is an **enzyme**, not a hormone. NSE is a glycolytic isoenzyme found in neurons and neuroendocrine cells. It serves as a diagnostic and prognostic marker for Small Cell Carcinoma of the Lung (SCLC) and Neuroblastoma, but it does not possess hormonal activity. **Analysis of Options:** * **b-HCG (beta-Human Chorionic Gonadotropin):** A glycoprotein hormone normally produced by the placenta. It is a classic hormonal marker for Gestational Trophoblastic Disease (Hydatidiform mole/Choriocarcinoma) and certain Germ Cell Tumors (e.g., Dysgerminoma, Non-seminomatous germ cell tumors) [3]. * **Calcitonin:** A hormone produced by the parafollicular C-cells of the thyroid [1]. It is the definitive tumor marker for **Medullary Carcinoma of the Thyroid (MTC)** and is used for both diagnosis and monitoring postoperative recurrence [2]. * **Catecholamines:** These are amine hormones (Epinephrine, Norepinephrine) and their metabolites (VMA, Metanephrines). They are secreted in excess by **Pheochromocytoma** (adrenal medulla) and Neuroblastoma [4]. **High-Yield Clinical Pearls for NEET-PG:** * **NSE:** Most specific marker for Small Cell Lung Cancer (SCLC). * **Calcitonin:** Used for screening family members in MEN 2A and 2B syndromes [2]. * **b-HCG:** Elevated in 100% of Choriocarcinomas and ~10% of pure Seminomas. * **Oncofetal Antigens:** Remember that CEA (Colon cancer) and AFP (HCC/Yolk sac tumor) are antigens, not hormones or enzymes [2]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 430-431. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1102-1103. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 512-513. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 419-420.
Question 84: Which of the following statements about embryonal rhabdomyosarcoma is false?
- A. It is typically seen in children younger than 5 years of age.
- B. It is a malignant tumor.
- C. It can have a gross appearance of grapelike clusters.
- D. Tumor cells contain 'tennis racket' granules. (Correct Answer)
Explanation: ### Explanation **Embryonal Rhabdomyosarcoma (ERMS)** is the most common soft tissue sarcoma in children [3]. The correct answer is **D** because "tennis racket" granules (Birbeck granules) are the pathognomonic ultrastructural hallmark of **Langerhans Cell Histiocytosis (LCH)**, not rhabdomyosarcoma [2]. #### Why Option D is False: In rhabdomyosarcoma, the characteristic ultrastructural findings are **thick and thin filaments** (actin and myosin) and **Z-discs**, reflecting its skeletal muscle origin. Histologically, one looks for **rhabdomyoblasts** (tadpole or strap cells) with cross-striations. #### Why the other options are True: * **Option A:** ERMS is primarily a pediatric tumor, with a peak incidence in children **under 5 years of age**. * **Option B:** It is a highly **malignant** mesenchymal tumor [3]. While the prognosis has improved with multimodal therapy, it remains an aggressive neoplasm. * **Option C:** A specific variant called **Sarcoma Botryoides** (found in hollow organs like the vagina or bladder) presents as a gelatinous, **grapelike mass** protruding from the mucosal surface [1]. #### NEET-PG High-Yield Pearls: * **Sarcoma Botryoides:** Look for the **"Cambium layer"** (a dense zone of tumor cells immediately beneath the intact epithelium) on histology. * **Immunohistochemistry (IHC):** The most specific markers are **Desmin, Myogenin (Myf4), and MyoD1** [3]. * **Genetics:** Unlike Alveolar Rhabdomyosarcoma (t(2;13) or t(1;13)), Embryonal Rhabdomyosarcoma typically shows gains or losses of chromosomes (e.g., trisomy 8) rather than specific translocations. * **Common Site:** Head and neck (orbit, nasopharynx) followed by the genitourinary tract. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Female Genital Tract, pp. 1004-1005. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, p. 630. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, pp. 1224-1225.
Question 85: Which of the following is not associated with thymoma?
- A. Red cell aplasia
- B. Myasthenia gravis
- C. Hypergammaglobulinemia (Correct Answer)
- D. Compression of the superior mediastinum
Explanation: **Explanation:** Thymoma is a tumor derived from thymic epithelial cells and is notorious for its association with various **paraneoplastic syndromes**, primarily due to the thymus's role in immune self-tolerance [3]. **Why Option C is correct:** Thymomas are classically associated with **Hypogammaglobulinemia** (specifically **Good Syndrome**), not hypergammaglobulinemia. Good Syndrome is characterized by thymoma, low B-cell and T-cell counts, and low antibody levels, leading to increased susceptibility to infections. **Why the other options are incorrect:** * **Option A (Red cell aplasia):** Pure Red Cell Aplasia (PRCA) is a well-known paraneoplastic manifestation of thymoma. * **Option B (Myasthenia gravis):** This is the most common association [1]. Approximately 30-45% of patients with thymoma have Myasthenia Gravis (MG), caused by autoantibodies against acetylcholine receptors (AChR) at the neuromuscular junction [2]. * **Option D (Compression of the superior mediastinum):** As thymomas are located in the anterior/superior mediastinum, large tumors can cause local "mass effect" symptoms, including Superior Vena Cava (SVC) syndrome, cough, dyspnea, and chest pain [3]. **NEET-PG High-Yield Pearls:** 1. **Most common anterior mediastinal mass:** Thymoma [4]. 2. **Good Syndrome Triad:** Thymoma + Hypogammaglobulinemia + Recurrent infections. 3. **Histology:** Look for a mixture of neoplastic epithelial cells and non-neoplastic reactive T-lymphocytes [5]. 4. **Staging:** The **Masaoka Staging System** is used to determine the prognosis based on capsular invasion. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 213-214. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Peripheral Nerves and Skeletal Muscles, pp. 1237-1238. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 572-574. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 571-572. [5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 634-635.
Question 86: Post-renal transplant lymphoma is mostly associated with which virus?
- A. Epstein-Barr virus (EBV) (Correct Answer)
- B. Cytomegalovirus (CMV)
- C. Herpes simplex virus (HSV)
- D. Human herpesvirus 6 (HHV-6)
Explanation: **Explanation:** Post-transplant lymphoproliferative disorder (PTLD) is a serious complication following solid organ or hematopoietic stem cell transplantation. The correct answer is **Epstein-Barr virus (EBV)**. [1] **Why EBV is the correct answer:** In the setting of post-renal transplant, patients are placed on potent immunosuppressive therapy (e.g., Cyclosporine, Tacrolimus) to prevent graft rejection. These drugs specifically inhibit T-cell surveillance. EBV, a B-lymphotropic virus, normally remains latent in B-cells. When T-cell control is lost, EBV undergoes uncontrolled replication, leading to B-cell proliferation [2]. This can progress from benign polyclonal hyperplasia to malignant monoclonal lymphoma (most commonly Diffuse Large B-cell Lymphoma). Approximately 90% of early-onset PTLD cases are EBV-positive. **Why other options are incorrect:** * **Cytomegalovirus (CMV):** While CMV is the most common viral infection post-transplant (causing fever, pneumonitis, or hepatitis), it is not oncogenic and does not cause lymphoma. * **Herpes Simplex Virus (HSV):** HSV typically causes mucocutaneous ulcers in immunocompromised patients but lacks transforming (oncogenic) potential. * **HHV-6:** This virus is associated with roseola infantum and occasionally encephalitis or graft dysfunction in transplant patients, but it is not a primary driver of post-transplant lymphoma. **High-Yield Clinical Pearls for NEET-PG:** * **Risk Factor:** The highest risk for PTLD occurs in "EBV-seronegative" recipients who receive an organ from an "EBV-seropositive" donor (Primary infection). * **Other EBV-associated Malignancies:** Burkitt Lymphoma (t[8;14]), Nasopharyngeal Carcinoma, Hodgkin Lymphoma (Mixed cellularity subtype), and Gastric Adenocarcinoma. [3] * **Management:** The first step in managing PTLD is often the **reduction of immunosuppressive therapy** to allow the patient's immune system to regain control over EBV-infected cells. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 181-182. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 261-263. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 219-220.
Question 87: The type of mammary ductal carcinoma in situ (DCIS) most likely to result in a palpable abnormality in the breast is
- A. Apocrine DCIS
- B. Neuroendocrine DCIS
- C. Well differentiated DCIS
- D. Comedo DCIS (Correct Answer)
Explanation: **Explanation:** **Comedo DCIS** is the most aggressive subtype of Ductal Carcinoma In Situ and is the most likely to present as a palpable mass or a vague area of induration [1]. **Why Comedo DCIS is the correct answer:** The hallmark of Comedo DCIS is the presence of high-grade pleomorphic nuclei and **extensive central necrosis** [2]. This necrotic debris often undergoes **dystrophic calcification**, which is typically seen as "linear or branching" microcalcifications on mammography [1]. The combination of periductal inflammation and significant periductal fibrosis (desmoplastic response) triggered by the necrotic material leads to the formation of a firm, palpable abnormality, unlike other non-comedo subtypes which are usually clinically occult. **Analysis of Incorrect Options:** * **Apocrine DCIS:** Characterized by cells with abundant eosinophilic granular cytoplasm (apocrine metaplasia). While it can be high-grade, it does not typically produce the massive necrosis and fibrosis seen in the comedo type. * **Neuroendocrine DCIS:** A rare variant where cells express neuroendocrine markers (e.g., chromogranin). It usually presents as an incidental finding or as mammographic calcifications rather than a palpable mass. * **Well-differentiated (Low-grade) DCIS:** These include patterns like cribriform or micropapillary DCIS [1]. They lack significant necrosis and usually present only as clustered microcalcifications on screening mammography, rarely forming a palpable lump [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Morphology:** Comedo DCIS is characterized by "toothpaste-like" necrotic material that can be extruded from the ducts upon pressure during gross examination. * **Paget Disease:** DCIS (especially high-grade/comedo) can migrate up the lactiferous ducts to the nipple skin, leading to Paget disease of the breast [1]. * **Van Nuys Prognostic Index:** Used to assess the risk of local recurrence in DCIS; it considers tumor size, margin width, nuclear grade, and comedo-type necrosis [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Breast, pp. 1062-1064. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 452-453.
Question 88: In which of the following carcinomas of the breast does loss of E-cadherin play a vital role in pathogenesis?
- A. Paget's disease
- B. Ductal carcinoma
- C. Lobular carcinoma (Correct Answer)
- D. Medullary carcinoma
Explanation: ### Explanation **Correct Option: C. Lobular carcinoma** The hallmark molecular feature of **Invasive Lobular Carcinoma (ILC)** and **Lobular Carcinoma in Situ (LCIS)** is the complete loss of **E-cadherin** expression. E-cadherin is a transmembrane glycoprotein responsible for calcium-dependent cell-cell adhesion. * **Pathogenesis:** A mutation in the *CDH1* gene (located on chromosome 16q22.1) leads to the loss of E-cadherin. * **Morphological Consequence:** Without this "cellular glue," tumor cells fail to adhere to one another, resulting in the characteristic **"single-file" (Indian file)** pattern of infiltration and a discohesive, rounded cell morphology [1]. **Analysis of Incorrect Options:** * **A. Paget’s Disease:** This is a manifestation of underlying ductal carcinoma (usually DCIS) where malignant cells (Paget cells) migrate to the nipple epidermis. It is not defined by E-cadherin loss. * **B. Ductal Carcinoma:** Unlike lobular types, Invasive Carcinoma of No Special Type (Ductal) **retains E-cadherin expression**. This allows the cells to adhere and form clusters, nests, or tubules [1]. * **D. Medullary Carcinoma:** This is a subtype of invasive ductal carcinoma characterized by a lymphoplasmacytic infiltrate and "pushing borders." It typically expresses E-cadherin. **High-Yield NEET-PG Pearls:** 1. **Diagnostic Marker:** Immunohistochemistry (IHC) for **E-cadherin** is the gold standard to differentiate between Ductal (Positive) and Lobular (Negative) carcinomas. 2. **Genetic Link:** Germline mutations in *CDH1* are associated with **Hereditary Diffuse Gastric Cancer (HDGC)**; these patients have a significantly high risk of developing Lobular Breast Carcinoma. 3. **Clinical Presentation:** Because lobular cells are discohesive, they often do not form a firm, palpable mass or show microcalcifications on mammography, making them harder to detect early [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 454-455.
Question 89: Hereditary retinoblastomas develop the following chromosomal detection?
- A. 13q14 (Correct Answer)
- B. 13p14
- C. 14p13
- D. 14q13
Explanation: **Explanation:** The correct answer is **13q14**. Retinoblastoma is the most common intraocular tumor of childhood [1]. It is caused by the inactivation of the **RB1 gene**, which was the first tumor suppressor gene to be discovered [3]. **1. Why 13q14 is correct:** The RB1 gene is located on the **long arm (q)** of **chromosome 13** at the **band 14** [1]. In hereditary retinoblastoma, a child inherits one defective copy of the RB1 gene (germline mutation) [2]. According to **Knudson’s "Two-Hit" Hypothesis**, a second somatic mutation in the retinal cells leads to tumor development [1]. Cytogenetic studies in these patients frequently show a microdeletion at the 13q14 locus. **2. Why the other options are incorrect:** * **13p14:** The "p" refers to the short arm of the chromosome. The RB1 gene is located on the long arm (q). * **14p13 & 14q13:** These refer to chromosome 14. While chromosome 14 is involved in other pathologies (like Robertsonian translocations or certain lymphomas), it is not the primary site for the RB1 gene. **High-Yield Clinical Pearls for NEET-PG:** * **Knudson’s Hypothesis:** Explains why hereditary cases are often **bilateral and multifocal**, whereas sporadic cases (where both hits occur somatically) are usually unilateral and unifocal [3]. * **Function of RB Protein:** It regulates the **G1 to S phase** transition of the cell cycle by binding to the E2F transcription factor. * **Morphology:** Look for **Flexner-Wintersteiner rosettes** (highly specific) and Homer-Wright rosettes [3]. * **Secondary Malignancy:** Patients with hereditary retinoblastoma have a significantly increased risk of developing **Osteosarcoma** later in life. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 300. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 227-228. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Manifestations Of Central And Peripheral Nervous System Disease, pp. 737-738.
Question 90: Metastasis to the liver is uncommon with which of the following malignancies?
- A. Colon
- B. Lung
- C. Breast
- D. Prostate (Correct Answer)
Explanation: **Explanation:** The liver is the most common site for blood-borne metastasis in the body (after regional lymph nodes) due to its dual blood supply and fenestrated endothelium [4]. However, the pattern of spread depends on the primary tumor's venous drainage. **Why Prostate is the correct answer:** Prostate cancer characteristically metastasizes to the **axial skeleton (bones)**, specifically the lumbar spine, pelvis, and femur [1, 2]. This occurs via the **Batson venous plexus**, a valveless vertebral venous system that connects the deep pelvic veins to the internal vertebral venous plexuses. While terminal-stage prostate cancer can involve the liver, it is statistically much less common compared to the other options provided. **Analysis of Incorrect Options:** * **Colon (A):** The liver is the most common site of metastasis for colorectal cancer. This is due to **portal circulation**; venous drainage from the intestinal tract travels directly to the liver via the portal vein [4]. * **Lung (B) & Breast (C):** Both are among the most common primary tumors that metastasize to the liver via the **systemic arterial circulation** [4]. The liver's high vascularity makes it a frequent "soil" for these "seeds." **NEET-PG High-Yield Pearls:** * **Most common site of metastasis overall:** Lymph nodes. * **Most common organ for metastasis:** Liver (second only to lymph nodes) [4]. * **Most common primary causing liver metastasis:** Colon > Pancreas > Breast > Lung. * **Osteoblastic metastasis:** Classically associated with Prostate Cancer (leads to increased Alkaline Phosphatase) [2, 3]. * **Exceptions to Liver Metastasis:** Malignancies that rarely spread to the liver include those of the brain (due to the Blood-Brain Barrier) and certain skin cancers like Basal Cell Carcinoma. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lower Urinary Tract and Male Genital System, pp. 989-994. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 501-502. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lower Urinary Tract and Male Genital System, pp. 993-994. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 282.
Practice by Chapter
Nomenclature and Classification of Tumors
Practice Questions
Characteristics of Benign and Malignant Neoplasms
Practice Questions
Molecular Basis of Cancer
Practice Questions
Carcinogenesis and Carcinogens
Practice Questions
Tumor Progression and Metastasis
Practice Questions
Tumor Markers
Practice Questions
Paraneoplastic Syndromes
Practice Questions
Genetic Basis of Cancer
Practice Questions
Tumor Immunity
Practice Questions
Cancer Epidemiology and Prevention
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free